HRAS T81C polymorphism modulates risk of urinary bladder cancer and predicts advanced tumors in ethnic Kashmiri population
Authors:
- Arshad A. PandithAPArshad A. Pandith
- Zafar A. ShahZSZafar A. Shah
- Nighat P. KhanNKNighat P. Khan
- Khalil M. BabaKBKhalil M. Baba
- M. Saleem WaniMWM. Saleem Wani
- Mushtaq A. SiddiqiMSMushtaq A. Siddiqi
- 1 May 2013
- journal article
- research article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 31 (4) , 487-492
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- The present and future burden of urinary bladder cancer in the worldWorld Journal of Urology, 2009
- Progress in the epidemiological understanding of gene–environment interactions in major diseases: cancerComptes Rendus. Biologies, 2007
- Ras family genes: An interesting link between cell cycle and cancerJournal of Cellular Physiology, 2002
- An Association between the Risk of Cancer and Mutations in the HRAS1 Minisatellite LocusNew England Journal of Medicine, 1993
- Epidemiological trend in the distribution of cancer in Kashmir Valley.Journal of Epidemiology and Community Health, 1993
- Concurrent mutations of coding and regulatory sequences of the Ha-ras gene in urinary bladder carcinomasHuman Pathology, 1992
- A Cytoplasmic Protein Stimulates Normal N- ras p21 GTPase, But Does Not Affect Oncogenic MutantsScience, 1987
- Nucleotide Sequence Analysis of the T24 Human Bladder Carcinoma OncogeneScience, 1983
- Complete nucleotide sequences of the T24 human bladder carcinoma oncogene and its normal homologueNature, 1983
- Activation of the T24 bladder carcinoma transforming gene is linked to a single amino acid changeNature, 1982